University Hospital in Motol

Futó vizsgálatok

• Még nem toboroz

  Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO

  NCT07499037· 2. fázis· University Hospital Ostrava· Forrás

• Toboroz

  International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

  NCT07476729· 3. fázis· Charite University, Berlin, Germany· Forrás

• Toboroz

  Pediatric Artificial Intelligence for Retinopathy Screening in Children With Type 1 Diabetes

  NCT07149142· University Hospital, Motol· Forrás

• Toboroz

  Revumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)

  2025-521390-14-00· 2. fázis· Pediatric Research International GmbH· Forrás

• Toboroz

  Phase I/II combination umbrella trial in progressive/relapsed/refractory pediatric low-grade glioma (pLGG) (EPILOGUE)

  2024-516896-34-00· 1/2. fázis· Universitaetsklinikum Heidelberg AöR· Forrás

• Toboroz

  A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer (HARMONi-GI3)

  2025-521587-35-00· 3. fázis· Summit Therapeutics Inc.· Forrás

• Toboroz

  Pregabalin or Baclofen in Spastic Motor Behavior Treatment After SCI (PoBSCI), Prospective, Double-Blind, Randomised Drug Study

  2024-518824-56-00· 3. fázis· Fakultni Nemocnice V Motole· Forrás

• Toboroz

  RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

  NCT07413939· 2/3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  2025-521546-23-00· 3. fázis· Novartis Pharma AG· Forrás

• Toboroz

  A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

  NCT07489495· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Még nem toboroz

  Low-dose versus standard-dose anticoagulation with argatroban or enoxaparin during extracorporeal membrane oxygenation controlled by anti-IIa or anti-Xa assay

  2025-524553-13-00· 2. fázis· Fakultni Nemocnice Ostrava· Forrás

• Toboroz

  A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  NCT07318558· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL

  NCT07297914· 2/3. fázis· Bambino Gesù Hospital and Research Institute· Forrás

• Még nem toboroz

  Time in rANge vs. Time in nOrmal Glycemia for Better Glycemic Control

  NCT07376850· University Hospital, Motol· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  NCT07221357· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

  NCT07218809· 3. fázis· AstraZeneca· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome

  NCT07219602· 3. fázis· NewAmsterdam Pharma· Forrás

• Toboroz

  Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia

  2025-520982-39-00· 3. fázis· Universita Degli Studi Di Milano Bicocca· Forrás

• Toboroz

  A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  NCT07276399· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

  NCT07170917· 2. fázis· Sanofi· Forrás

• Toboroz

  A Study to Evaluate the Long-term Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis

  2024-519795-11-00· 2. fázis· Apogee Therapeutics Inc.· Forrás

• Toboroz

  Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  NCT06982521· 3. fázis· Relay Therapeutics, Inc.· Forrás

• Toboroz

  Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  NCT07044336· 3. fázis· AstraZeneca· Forrás

• Toboroz

  This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  NCT06758401· 3. fázis· Pfizer· Forrás

• Toboroz

  A Phase 1b/2a Trial to Evaluate Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care.

  NCT06832722· 1/2. fázis· 4TEEN4 Pharmaceuticals GmbH· Forrás

• Fut, nem toboroz

  Support C Post-Market Registry

  NCT06678490· OrbusNeich· Forrás

• Fut, nem toboroz

  An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

  NCT06991556· 2. fázis· Novartis Pharmaceuticals· Forrás

• Fut, nem toboroz

  A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

  NCT07047118· 2. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  INNODIA Family & Friends Early-Stage T1D Detection Protocol

  NCT07118098· INNODIA iVZW· Forrás

• Fut, nem toboroz

  Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa

  NCT06940830· 4. fázis· Swedish Orphan Biovitrum· Forrás

• Toboroz

  International open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide in pediatric, adolescent, and adult patients with GD2-positive Ewing sarcoma

  2024-515245-42-00· 1. fázis· GPOH gGmbH· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa

  NCT06840392· 3. fázis· Novartis Pharmaceuticals· Forrás

• Fut, nem toboroz

  EucaLimus Post-Market Registry

  NCT06621524· OrbusNeich· Forrás

• Fut, nem toboroz

  A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

  NCT06764485· 3. fázis· Celgene· Forrás

• Toboroz

  Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

  NCT06855498· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· 3. fázis· Daiichi Sankyo· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis

  NCT06878404· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

  2022-502352-31-00· 3. fázis· Amgen Inc.· Forrás

• Fut, nem toboroz

  Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer

  NCT06619236· 3. fázis· Genmab· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

  NCT06807424· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.

  NCT06382948· 3. fázis· MedSIR· Forrás

• Meghívásos bevonás

  The Effect of DNS Therapy on Asymmetry in Children After Surgery of Congenital Heart Disease

  NCT06776822· Charles University, Czech Republic· Forrás

• Fut, nem toboroz

  A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

  NCT06616194· 3. fázis· Pfizer· Forrás

• Fut, nem toboroz

  Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018

  2022-501457-37-00· 3. fázis· GPOH gGmbH· Forrás

• Toboroz

  Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients with Cystic Fibrosis

  2024-511184-28-00· 2. fázis· Splisense Ltd.· Forrás

• Toboroz

  The randomized, double blind study phase III.b of the Comprehensive assessment of the musculoskeletal health in children with cystic fibrosis – on the search for means of improvement

  2024-517886-18-00· 3. fázis· Fakultni Nemocnice V Motole· Forrás

• Toboroz

  A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

  NCT06545955· 3. fázis· Ferring Pharmaceuticals· Forrás

• Toboroz

  Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

  NCT06467357· 3. fázis· AstraZeneca· Forrás

• Meghívásos bevonás

  Long-term Safety and Tolerability of BHV-7000

  NCT06443463· 2. fázis· Biohaven Therapeutics Ltd.· Forrás

• Toboroz

  Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

  NCT06252649· 3. fázis· Amgen· Forrás

Showing 50 of 130.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok23 toboroz
• Akut limfoid leukémia (ALL)6 toboroz
• Szarkóma4 toboroz
• Vastagbélrák4 toboroz
• 1-es típusú cukorbetegség3 toboroz
• Áttétes emlőrák3 toboroz
• Cisztás fibrózis3 toboroz
• Epilepszia3 toboroz
• Petefészekrák3 toboroz
• Szívelégtelenség3 toboroz
• Vesedaganat3 toboroz
• Hólyagrák2 toboroz
• Koszorúér-betegség2 toboroz
• Méhtestrák2 toboroz
• Neuroblasztóma2 toboroz
• Prosztatarák2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Congenital heart disease1 toboroz
• Diabéteszes retinopátia1 toboroz
• Down syndrome1 toboroz
• Duchenne-izomdisztrófia1 toboroz
• Fej-nyaki daganatok1 toboroz
• Friedreich-ataxia1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Hemofília1 toboroz
• Hidradenitis suppurativa1 toboroz
• Hodgkin-limfóma1 toboroz
• Krónikus vesebetegség1 toboroz
• Máj- és epeúti rák1 toboroz
• Pitvarfibrilláció1 toboroz
• Sclerosis multiplex (SM)1 toboroz
• Spinal cord injury1 toboroz
• Tüdőrák1 toboroz
• Vitiligo1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures

  2025-524038-24-00· 3. fázis· Praxis Precision Medicines Inc.· Forrás

• Lezárult

  Phase 2b Randomized, Double-Blind Study with Phage for CF Subjects with Pseudomonas Lung Infection

  2024-519856-94-00· 2. fázis· Biomx Ltd.· Forrás

• Toboroz

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· 3. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

  NCT06521567· 1/2. fázis· GlaxoSmithKline· Forrás

• Fut, nem toboroz

  A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD L1 high NSCLC

  2023-504753-12-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa

  2024-511363-28-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa

  NCT06603077· 2. fázis· Avalo Therapeutics, Inc.· Forrás

• Toboroz

  Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

  NCT06282575· 3. fázis· Jazz Pharmaceuticals· Forrás

• Lezárult

  Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)

  NCT06506773· Vertex Pharmaceuticals Incorporated· Forrás

• Lezárult

  Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis

  NCT06430671· 1. fázis· Cellerys AG· Forrás

• Toboroz

  A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

  NCT06056297· 3. fázis· X4 Pharmaceuticals· Forrás

• Lezárult

  A Phase IIb, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Subjects with Cystic Fibrosis Aged 18 Years or Older (CHOICES)

  2022-500410-26-01· 2. fázis· University Medical Center Utrecht· Forrás

• Leállították

  REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction

  NCT06237309· 2. fázis· Regeneron Pharmaceuticals· Forrás

• Fut, nem toboroz

  A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease

  NCT05970172· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Fut, nem toboroz

  A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

  NCT06105632· 2. fázis· Pfizer· Forrás

• Toboroz

  A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

  NCT05995353· 3. fázis· AbbVie· Forrás

• Lezárult

  A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)

  NCT05882877· 3. fázis· Amgen Inc.· Forrás

• Lezárult

  A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

  NCT05958407· 3. fázis· LEO Pharma· Forrás

• Lezárult

  EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma

  NCT06390059· 2. fázis· NovoCure Ltd.· Forrás

• Toboroz

  Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

  NCT05855200· 3. fázis· GlaxoSmithKline· Forrás

• Lezárult

  An 18-month study to assess joint outcomes in patients with haemophilia A or B on prophylaxis with efmoroctocog alfa or eftrenonacog alfa

  2022-502921-16-00· 4. fázis· Swedish Orphan Biovitrum AB (publ)· Forrás

• Lezárult

  A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke

  NCT05953480· 2. fázis· Shionogi· Forrás

• Lezárult

  A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa

  NCT05849922· 2. fázis· Sanofi· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)

  2024-517612-29-00· 4. fázis· The Brigham And Women’s Hospital Inc.· Forrás

• Toboroz

  A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  NCT05667142· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás

• Leállították

  A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

  NCT05732454· 2/3. fázis· Pfizer· Forrás

• Lezárult

  Study to assess safety and identify dose of ribociclib in combination of temozolomide and topotecan (TOTEM) in patients (12 months – 21 years old) with relapsed or refractory solid tumors (Phase I), and further assess efficacy and safety in patients (12 months – 21 years old) with relapsed or refractory neuroblastoma (Phase II)

  NCT05429502· 1/2. fázis· Novartis Pharma AG· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT05620823· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke

  NCT05643573· 3. fázis· Bayer AG· Forrás

• Lezárult

  Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)

  NCT05776459· 2. fázis· AudioCure Pharma GmbH· Forrás

• Fut, nem toboroz

  Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

  NCT05206357· 1. fázis· Genmab· Forrás

• Lezárult

  A Study of Relatlimab-nivolumab Fixed-dose Combination versus Regorafenib or TAS-102 in Participants with Later-lines of Metastatic Colorectal Cancer

  NCT05328908· 3. fázis· Bristol Myers Squibb International Corporation· Forrás

• Lezárult

  A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®

  NCT05405725· 3. fázis· Enzene Biosciences Ltd.· Forrás

• Lezárult

  Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

  NCT05010577· 1/2. fázis· BiomX, Inc.· Forrás

• Lezárult

  A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

  NCT05398445· 3. fázis· Amgen· Forrás

• Lezárult

  Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma

  NCT05218499· 2/3. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria

  NCT05196035· 3. fázis· Bayer· Forrás

• Lezárult

  A Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety and Radiological and Clinical Effects of Subcutaneous (SC) Ocrelizumab versus Intravenous (IV) Ocrelizumab in Patients with Multiple Sclerosis

  2023-505975-54-00· 3. fázis· F. Hoffmann-La Roche AG· Forrás

• Fut, nem toboroz

  Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

  NCT05348577· 3. fázis· AstraZeneca· Forrás

• Lezárult

  A clinical study to investigate if the investigational drug Diamyd is safe and can preserve insulin production and secretion in adolescents and adults that have recently been diagnosed type 1 diabetes. The safety of Diamyd will also be investigated. Some subjects may receive a placebo drug.

  NCT05018585· 3. fázis· Diamyd Medical AB· Forrás

• Lezárult

  Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumours

  2024-511071-16-00· 1. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia (FTD-GRN)

  NCT05262023· 1/2. fázis· Denali Therapeutics Inc.· Forrás

• Lezárult

  A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)

  NCT05064059· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cytometer

  NCT05035615· Becton, Dickinson and Company· Forrás

• Fut, nem toboroz

  Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

  NCT05043090· 3. fázis· AstraZeneca· Forrás

• Lezárult

  Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis

  NCT05087030· 3. fázis· Gedeon Richter Plc.· Forrás

• Lezárult

  A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

  NCT05033080· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Fut, nem toboroz

  A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

  NCT04908202· 3. fázis· Bristol-Myers Squibb· Forrás

• Fut, nem toboroz

  Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

  NCT04793958· 3. fázis· Mirati Therapeutics Inc.· Forrás

Showing 50 of 87.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Akut limfoid leukémia (ALL)13 munka · 11 vizsgálat
• Hemofília7 munka · 6 vizsgálat
• Spinális izomatrófia (SMA)6 munka · 1 vizsgálat